1. Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas

   • Chrissa Sioka
   • Athanassios P. Kyritsis

   Topic review 21 November 2008 Pages: 1 - 6

2. Different pattern of expression of nestin in the non-specific form of dysembryoplastic neuroepithelial tumors compared to the simple and complex forms

   • Chang Ohk Sung
   • Yeon-Lim Suh

   Laboratory investigation - human/animal tissue 08 November 2008 Pages: 7 - 13

   

3. Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2′-deoxycytidine in glioma cells

   • Sachie Oi
   • Atsushi Natsume
   • Toshihiko Wakabayashi

   Laboratory investigation - human/animal tissue 22 November 2008 Pages: 15 - 22

   

4. Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model

   • Gaspar J. Kitange
   • Brett L. Carlson
   • Jann N. Sarkaria

   Labatory investigation - human/animal tissue 15 November 2008 Pages: 23 - 31

   

5. Tuberculosis in a patient on temozolomide: a case report

   • Tadeu Ferreira de Paiva Jr.
   • Milton José de Barros e Silva
   • Daniel Luiz Gimenes

   Clinical study - patient study 01 November 2008 Pages: 33 - 35

   

6. Is biopsy needed to guide management for all patients with presumed intracranial ectopic germinomas

   • Chenglin Tian
   • Chuanqiang Pu
   • Shuxiang Cui

   Clinical study - patient study 26 October 2008 Pages: 37 - 44

   

7. ACNU-based chemotherapy for recurrent glioma in the temozolomide era

   • Caroline Happold
   • Patrick Roth
   • Günter Eisele

   Clinical study - Patient Study 06 November 2008 Pages: 45 - 48

   

8. Cognition before and after chemotherapy alone in children with chiasmatic-hypothalamic tumors

   • Daria Riva
   • Maura Massimino
   • Sara Bulgheroni

   Clinical Study - Patient Study 14 November 2008 Pages: 49 - 56

9. Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma

   • T. Mikkelsen
   • T. Doyle
   • L. Schultz

   Clinical study - patients study 15 November 2008 Pages: 57 - 63

   

10. Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: role of STAT6 activation as prognostic determinant

    • Seung-Ho Yang
    • Kun Soo Lee
    • Yong-Kil Hong

    Clinical study - patient study 22 November 2008 Pages: 65 - 71

    

11. Fatigue in low-grade glioma

    • Karin Struik
    • Martin Klein
    • Tjeerd J. Postma

    Clinical Study - Patient Study Open access 09 December 2008 Pages: 73 - 78

12. A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma

    • Maria Grazia Fabrini
    • Giovanni Silvano
    • Luca Cionini

    Clinical study - patient study 19 November 2008 Pages: 79 - 86

    

13. Clinical epidemiology for childhood primary central nervous system tumors

    • Luc Bauchet
    • Valérie Rigau
    • Association des Neuro-Oncologues d’Expression Française

    Clinical Study - Patient Study 20 November 2008 Pages: 87 - 98

14. A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)

    • Teri N. Kreisl
    • Andrew B. Lassman
    • Lauren E. Abrey

    Clinical Study - Patient Study 19 November 2008 Pages: 99 - 105

    

15. Melanocytoma in the orbital apex

    • Kazufumi Sato
    • Toshihiko Kubota
    • Kazuhiko Yoshida

    Case Report 24 October 2008 Pages: 107 - 110

    

16. Expression of HIF-1, galectin-3, cox-2 and Wilms tumor-1 protein in multiple schwannomas of the conus medullaris

    • Amr M. Sarwat
    • Suhail Al-Salam

    Case Report 09 November 2008 Pages: 111 - 115

    

17. Rosai-Dorfman disease manifesting as intracranial and intraorbital lesion

    • Archana Hinduja
    • L. Giselle Aguilar
    • Joseph C. Landolfi

    Case report 20 November 2008 Pages: 117 - 120